How cenobamate works as early add-on treatment for epilepsy
Treatments studied
Part of Brain & nervous system clinical trials.
This study looks at how well cenobamate works when added to other seizure medications for adults with focal epilepsy. It uses real-world data from medical records to see how people respond to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have epilepsy with seizures that start in one part of the brain (focal seizures), which may spread.
- You have tried 2 or 3 anti-seizure medications before, but they did not control your seizures well enough.
- You are currently taking cenobamate as an add-on treatment and have not yet reached your final dose.
- You have medical records showing your seizure count for the 3 months before starting cenobamate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called probenecid can help reduce the number of seizures that happen in a cluster during a hospital stay when your seizure medications are being reduced to record your seizures. The goal is to see if giving probenecid can make the monitoring period safer and more effective for people with focal epilepsy being evaluated for surgery.
This study looks at how cenobamate (a medication for seizures) affects healthcare use, like hospital visits or emergency room trips, in people with epilepsy whose seizures were not well-controlled by 2 to 5 other medicines. It is a real-world study, meaning it uses medical records to understand the impact.
This trial tests a seizure medicine called cenobamate for people in the ICU who are having frequent seizures or a type of prolonged seizure called status epilepticus. It aims to see if this add-on treatment can help control seizures in this setting.
This trial studies the safety of cenobamate for Japanese people who have partial onset seizures and have already finished a previous study of the same drug. It helps doctors learn more about long-term safety.
This trial tests whether a new seizure medicine (cenobamate) helps people whose seizures are caused by an overactive immune system. You would stay on your current treatments and add cenobamate to see if it reduces seizures.
This study tests a new medicine (ONO-2017) for people with a type of epilepsy that causes whole-body seizures. It looks at whether adding this drug to your current seizure medicines can reduce how often those seizures happen.
Hear when a new Focal Epilepsy With and Without Secondary Generalization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.